A detailed history of Chelsea Counsel CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chelsea Counsel CO holds 22,675 shares of MRK stock, worth $2.25 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
22,675
Previous 22,765 0.4%
Holding current value
$2.25 Million
Previous $2.82 Million 8.66%
% of portfolio
1.28%
Previous 1.42%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

SELL
$111.15 - $128.97 $10,003 - $11,607
-90 Reduced 0.4%
22,675 $2.57 Million
Q2 2024

Nov 21, 2024

SELL
$123.8 - $132.96 $6,932 - $7,445
-56 Reduced 0.25%
22,765 $2.82 Million
Q1 2024

Jun 14, 2024

SELL
$113.24 - $131.95 $271,776 - $316,680
-2,400 Reduced 9.52%
22,821 $3.01 Million
Q4 2023

Feb 21, 2024

SELL
$100.18 - $109.02 $400,720 - $436,080
-4,000 Reduced 13.69%
25,221 $2.75 Million
Q1 2023

May 19, 2023

BUY
$102.94 - $114.86 $10,294 - $11,486
100 Added 0.34%
29,221 $3.11 Million
Q4 2022

Feb 23, 2023

BUY
$87.44 - $112.11 $43,720 - $56,055
500 Added 1.75%
29,121 $3.23 Million
Q3 2022

Oct 31, 2022

SELL
$84.53 - $94.96 $470,747 - $528,832
-5,569 Reduced 16.29%
28,621 $2.47 Million
Q2 2022

Aug 01, 2022

SELL
$83.49 - $94.64 $3,339 - $3,785
-40 Reduced 0.12%
34,190 $3.12 Million
Q1 2022

May 24, 2022

SELL
$73.51 - $82.4 $9,335 - $10,464
-127 Reduced 0.37%
34,230 $2.81 Million
Q3 2021

Feb 10, 2022

SELL
$71.68 - $78.83 $17,203 - $18,919
-240 Reduced 0.69%
34,357 $2.58 Million
Q1 2021

Feb 10, 2022

SELL
$68.86 - $81.11 $6,886 - $8,111
-100 Reduced 0.29%
34,597 $2.67 Million
Q4 2020

Mar 08, 2022

SELL
$71.77 - $79.65 $51,172 - $56,790
-713 Reduced 2.01%
34,697 $2.84 Million
Q3 2020

May 06, 2022

SELL
$73.18 - $82.95 $73 - $82
-1 Reduced -0.0%
35,410 $2.94 Million
Q2 2020

May 06, 2022

BUY
$70.42 - $80.13 $122,460 - $139,346
1,739 Added 5.16%
35,411 $2.74 Million
Q1 2020

Jun 12, 2020

BUY
$63.36 - $87.82 $204,906 - $284,009
3,234 Added 10.62%
33,672 $2.59 Million
Q4 2019

Mar 23, 2020

BUY
$77.58 - $87.54 $102,017 - $115,115
1,315 Added 4.52%
30,438 $2.77 Million
Q3 2019

Mar 27, 2020

BUY
$76.08 - $82.93 $3,804 - $4,146
50 Added 0.17%
29,123 $2.45 Million
Q3 2019

Mar 23, 2020

SELL
$76.08 - $82.93 $618,150 - $673,806
-8,125 Reduced 21.84%
29,073 $0
Q2 2019

Dec 09, 2019

BUY
$69.84 - $81.59 $57,827 - $67,556
828 Added 2.28%
37,198 $3.12 Million
Q3 2018

Dec 09, 2019

SELL
$57.69 - $67.84 $46,325 - $54,475
-803 Reduced 2.16%
36,370 $2.58 Million
Q2 2018

Oct 03, 2018

BUY
$50.83 - $59.72 $1.24 Million - $1.45 Million
24,300 Added 188.77%
37,173 $2.26 Million
Q3 2017

Jan 12, 2018

BUY
$58.67 - $63.13 $176 - $189
3 Added 0.02%
12,873 $824,000
Q2 2017

Jan 22, 2018

BUY
N/A
12,870
12,870 $825,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Chelsea Counsel CO Portfolio

Follow Chelsea Counsel CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.